Hong Kong homebuyers snapped up new launches on Tuesday as developers accelerated sales amid concerns over slower rate cuts and geopolitical tensions in the Middle East. By about 3.50pm, all 254 flats released at the La Mirabelle project in Tseung Kwan O had been sold, according to market agents. La Mirabelle in Harbour Bay – jointly developed by Sino Group, Kerry Properties, K. Wah International,...
Hong Kong homebuyers snapped up new launches on Tuesday as developers accelerated sales amid concerns over slower rate cuts and geopolitical tensions in the Middle East. By about 3.50pm, all 254 flats released at the La Mirabelle project in Tseung Kwan O had been sold, according to market agents. La Mirabelle in Harbour Bay – jointly developed by Sino Group, Kerry Properties, K. Wah International, China Merchants Land and MTR Corporation – is to be developed in two phases, each comprising about...
MicroStockHub/iStock via Getty Images Overview When I previously covered the abrdn Healthcare Opportunities Fund ( THQ ), I issued a hold rating due to the sector headwinds and limited growth potential at the time. Since my last coverage , THQ has traded lower as the rest of the market indices continue to pull back from their all-time highs. However, the fund has released an updated annual report,...
MicroStockHub/iStock via Getty Images Overview When I previously covered the abrdn Healthcare Opportunities Fund ( THQ ), I issued a hold rating due to the sector headwinds and limited growth potential at the time. Since my last coverage , THQ has traded lower as the rest of the market indices continue to pull back from their all-time highs. However, the fund has released an updated annual report, and I believe there are some growth catalysts that can lead to attractive total returns as interest rates trend lower. Therefore, I wanted to revisit the fund to provide some updated insights into its performance and potential for a sustainable source of income generation. Following the recent pullback in share price, the fund now trades at a small discount to NAV of 1.71%. However, this is a bit smaller than the discount to NAV of 2.7% at the time of my last coverage. Referring to the red line on the graph below, we can see that the fund still trades at the higher end of its price-to-NAV range. However, I believe that management's decision to raise the payouts back in 2024 helped artificially to deflate the price-to-NAV discount. Looking forward, I believe that lower rates and an expanding GLP-1 market will serve as catalysts over the next twelve months. CEF Data THQ now offers a dividend yield of about 13% and issues its payouts on a monthly basis. However, the recent annual report indicates that the fund struggled to generate earnings that could actually support those payouts. As a result, THQ's underlying NAV has declined year-over-year. If the fund continues to pay out more than it earns, I believe there is still more downside risk, especially since the fund uses a moderate amount of leverage. Therefore, I wouldn't be against a reduction of the distribution to help the fund's performance improve. Fund Strategy According to the latest fact sheet , THQ has total managed assets of $1.02B that are spread across a diverse range of healthcare-focused positions. The fund tak...